Completion of non-exclusive discounts according to § 130a para. 8 SGB W at any time with a so-called closing option ‘open-house contracts’ for pharmaceutical active substances zonisamide and xylometazolin.
Completion of non-exclusive discounts according to § 130a para. 8 SGB V with any possibility to conclude at so-called ‘open-house contracts’ for the drug active substance duloxetin.
Completion of non-exclusive discounts according to § 130a para. 8 SGB V with any possibility to conclude at so-called “Open-House contracts” for Glatiramer acetate.
Completion of non-exclusive discounts according to § 130a para. 8 SGB W at any time with a so-called closing option ‘open-house contracts’ for Aripiprazole and Tramadol/Paracetamol.
Completion of non-exclusive discounts according to § 130a para. 8 SGB V with any possibility to conclude at so-called “Open-House contracts” for various active ingredients.